Skip to main content
Premium Trial:

Request an Annual Quote

Dutch Biomarker Firm ACS Biomarker Closes Financing, Appoints New CEO

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ACS Biomarker reported on Friday it has closed on a financing round and appointed a new CEO.

The amount of the funding was not disclosed. In a statement, the company, based in Maastricht, Netherlands, said it will be used to further develop its product pipeline and discover novel biomarkers "that improve diagnosis, prognosis, and management of cardiac diseases."

Funding came from Life Sciences Fund Amsterdam and Limburg Ventures, ACS said.

ACS Biomarker, spun out of Maastricht University Medical Centre in 2007, recently established an office and research facility in Amsterdam. Its R&D is focused on miRNA- and protein-based cardiovascular biomarkers.

Its first protein biomarker, galectin-3, was licensed to BG Medicine, whose test for heart failure based on the biomarker was cleared by the US Food and Drug Administration in November.

The company also said it has appointed a new CEO, Heico Breek, who said in a statement that his main objective will be on the expansion and commercialization of ACS Biomarker's portfolio.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.